BAHEAL ONLINE officially announced on October 9, 2015 that it would cooperate with Guizhou Yibai Pharmaceutical Co., Ltd. (hereinafter referred to as "Yibai Pharmaceutical") to establish a joint venture Guizhou Baheal Yibai Tumor Easy-Recheck Big Data Co., Ltd., and jointly launched a brand new tumor post-diagnosis management platform “Tumor Easy-Recheck”.

Based on the existing easy-recheck platform, the “Tumor Easy-Revisit” will carry out the exploration and promotion of vertical applications related to cancer patients, so as to better serve patients with chronic diseases through developing more vertical applications for tumor easy-recheck.

Hu Jiayue, COO of Baiyjk.com, said, “We are honored to collaborate with Yibai Pharmaceutical to establish a tumor easy-recheck company and to expand business in the big data market on tumor. The Tumor Easy-Recheck Platform will utilize the existing easy-recheck platform to carry out exploration and promotion of vertical applications related to cancer patients. The platform will provide shared information and supporting services to hospitals, doctors, patients, enterprises and governmental departments, and share data to help government control healthcare costs and facilitate the disease research and patient’s rehabilitation.”

Lang Hongping, CEO of Yibai Pharmaceutical, said that after a careful selection and an in-depth investigation, Yibai Pharmaceutical finally chose the easy-recheck as the partner to set up the information service platform for tumor patients. The platform has a wide coverage and features sound functions in line with medical scenes and China’s national policies, which boasted higher enforceability. Yibai Pharmaceutical has launched its strategy of “focus on tumor big data and embrace the Internet” this year. In terms of focusing on tumor big data, the company will forge the industrial closed loop of such related aspects as cancer prevention, cancer rehabilitation, cancer gene sequencing, cancer immunotherapy, cancer treatment equipment rental and public welfare institute tumors. Meanwhile, Yibai Pharmaceutical will also utilize Internet technologies to establish several platforms like the tumor big data center, tumor treatment App, online cancer hospital, remote consultation, electronic medical records in chain hospitals, oncologist Apps and medical e-commerce.

Under the cooperation framework, it is planed that over 20, 000 tumor doctors and over 200,000 cancer patients will be covered by June 30, 2016, and the exploration on data scientific and technological projects will be carried out in the area of tumor and chronic diseases, so as to better serve the patients.